Amiodarone-induced Acute Respiratory Distress Syndrome Developed after Increasing Dosage of Amiodarone
Soonchunhyang Medical Science
;
: 155-158, 2012.
Artículo
en Coreano
| WPRIM
| ID: wpr-110152
ABSTRACT
Amiodarone is a highly effective antiarrhythmic agent. It is commonly used to treat ventricular and supraventricular arrhythmias. However, amiodarone has been found to be associated with a variety of adverse effects. Amiodarone causes toxicity to organs such as lung, gastrointestinal tract, liver, eye, thyroid gland, skin, and neuromuscular system. Among these side effects, pulmonary toxicity is one of the most serious ones. The prevalence of amiodarone-induced pulmonary toxicity is not known precisely, but recent studies have reported that incidence rates range from 1% to 13%. The risk factors associated with the development of pulmonary toxicity are age, duration of treatment, cumulative dosage, history of cardiothoracic surgery, and use of high oxygen mixture. Amiodarone use has been rarely related to development of acute respiratory distress syndrome (ARDS), which is often in association with surgery or pulmonary angiography. We experienced a case of amiodarone-induced ARDS which developed after an increase of amiodarone dosage.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Oxígeno
/
Arritmias Cardíacas
/
Síndrome de Dificultad Respiratoria
/
Piel
/
Glándula Tiroides
/
Angiografía
/
Incidencia
/
Prevalencia
/
Factores de Riesgo
/
Tracto Gastrointestinal
Tipo de estudio:
Estudio de etiología
/
Estudio de incidencia
/
Estudio de prevalencia
/
Estudio pronóstico
/
Factores de riesgo
Idioma:
Coreano
Revista:
Soonchunhyang Medical Science
Año:
2012
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS